Healthcare & Life Sciences
Immunic AG
Germanyimmunic.co
Immunic AG is a Healthcare & Life Sciences startup based in Germany, most recent round Series C+, 4 tracked investors.
IPOseries-c-plus
series-c-plus
Stage
2007
Founded
4
Investors
About Immunic AG
Immunic AG is a startup founded in 2007 based in Germany. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Immunic is a late-stage biotechnology company developing orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, including multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.
Explore Immunic AG's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.